6-[[2-(二甲基氨基)乙基]氨基]-3-羟基-7H-茚并[2,1-C]喹啉-7-酮二盐酸盐
中文名称 | 6-[[2-(二甲基氨基)乙基]氨基]-3-羟基-7H-茚并[2,1-C]喹啉-7-酮二盐酸盐 |
---|---|
中文同义词 | 6-[[2-(二甲基氨基)乙基]氨基]-3-羟基-7H-茚并[2,1-C]喹啉-7-酮二盐酸盐;拓扑异构酶I和II抑制剂(TAS-103双盐酸盐);TAS-103(BMS-247615)盐;TAS-103双盐酸盐;化合物TAS-103 (DIHYDROCHLORIDE) |
英文名称 | TAS 103 |
英文同义词 | TAS-103 (dihydrochloride);TAS-103(2HCl);TAS-103(BMS-247615);6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride;BMS-247615-2HCl;BMS 247615 dihydrochloride;BMS247615 dihydrochloride;BMS-247615 dihydrochloride |
CAS号 | 174634-09-4 |
分子式 | C20H21Cl2N3O2 |
分子量 | 406.30564 |
EINECS号 | |
相关类别 | 细胞生物学试剂 |
Mol文件 | 174634-09-4.mol |
结构式 |
6-[[2-(二甲基氨基)乙基]氨基]-3-羟基-7H-茚并[2,1-C]喹啉-7-酮二盐酸盐 性质
储存条件 | under inert gas (nitrogen or Argon) at 2-8°C |
---|---|
溶解度 | PBS (pH 7.2):1.0(最大浓度 mg/mL);2.46(最大浓度 mM) |
形态 | 结晶固体 |
Topoisomerase I
|
Topoisomerase II
|
TAS-103 is a dual inhibitor of DNA topoisomerase I/II. TAS-103 (0.1-10 μM) is active on CCRF-CEM cells, with an IC 50 value of 5 nM. TAS-103 (0.1 μM) significantly increases levels of topo IIα FITC immunofluorescence in individual CCRF-CEM cells. TAS-103 (0.01-1 μM) is highly cytotoxic to Lewis lung carcinoma (LLC) cells, and Liposomal TAS-103 is almost as active as free TAS-103. TAS-103 inhibits the viability of HeLa cells, with an IC 50 of 40 nM. TAS-103 (10 μM) disrupts signal recognition particle (SRP) complex formation, and induces destabilization of SRP14 and SRP19 and its eventual degradation.
TAS-103 (30 mg/kg, i.v.) causes significant tumor growth suppression in mice bearing Lewis lung carcinoma (LLC) cells, without obvious body weight loss, and the liposomal TAS-103 is more active than free TAS-103.
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/01/25 | HY-13758A | TAS-103 dihydrochloride | 1 mg | 500元 | |
2024/01/25 | HY-13758A | 6-[[2-(二甲基氨基)乙基]氨基]-3-羟基-7H-茚并[2,1-C]喹啉-7-酮二盐酸盐 TAS-103 dihydrochloride | 174634-09-4 | 5mg | 1100元 |